Supply Chain Innovations in Health Care

2015 ◽  
pp. 320-331
Keyword(s):  
2021 ◽  
pp. 2516600X2098735
Author(s):  
Mahdi Safa ◽  
Nomita Sharma ◽  
Pamela Zelbst

We learn painful lessons these days about the hidden weaknesses in the supply chains, while the surge reflects a new inflection point of the COVID-19 outbreak. Healthcare experts, politicians, academics, and supply chain practitioners need to collaborate to build a reform agenda and roadmap for our humanitarian supply chain. This study aims at investigating and assessing risks on the supply chain, especially for health care supplies. The theme of the article is based on the development of an information-driven model to help in the assessment of supply chain risk. An integrative review technique has been used to analyze literature to develop prepositions for the model. The main actors of the model are supply chain preparedness, supply chain risk, supply chain response, and supply chain recovery. The findings identify that timely preparation and assessment of supply chain risk can result in accurate adoption of the practices that can not only reduce supply chain risk but also enhance supply chain recovery during any catastrophic event.


foresight ◽  
2021 ◽  
Vol ahead-of-print (ahead-of-print) ◽  
Author(s):  
Sriyanto Sriyanto ◽  
Muhammad Saeed Lodhi ◽  
Hailan Salamun ◽  
Sardin Sardin ◽  
Chairil Faif Pasani ◽  
...  

Purpose The study aims to examine the role of health-care supply chain management during the COVID-19 pandemic in a cross-section of 42 selected sub-Saharan African (SSA) countries. Design/methodology/approach The study used cross-sectional robust least square regression for parameter estimates. Findings The results confirmed the N-shaped relationship between the health-care logistics performance index (HLPI) and COVID-19 cases. It implies that initially HLPI increases along with an increase in COVID-19 cases. Later down, it decreases COVID-19 cases by providing continued access to medical devices and personal protective equipment. Again, it increases due to resuming economic activities across countries. Practical implications The continuing health-care supply chain is crucial to minimize COVID-19 cases. The international support from the developed world in providing health-care equipment, debt resettlement and resolving regional conflicts is deemed desirable to escape the SSA countries from the COVID-19 pandemic. Originality/value The importance of the health-care supply chain during the COVID-19 pandemic is evident in the forecasting estimates, which shows that from August 2021 to April 2022, increasing the health-care supply chain at their third-degree level would reduce coronavirus registered cases. The results conclude that SSA countries required more efforts to contain coronavirus cases by thrice increasing their health-care logistics supply chain.


2013 ◽  
Vol 4 (2) ◽  
Author(s):  
Raeeda Jamal Al-Saa'da ◽  
Yara Khalid Abu Taleb ◽  
Mais Elian Al Abdallat ◽  
Rasmi Abd Alraheem Al-Mahasneh ◽  
Nabil Awni Nimer ◽  
...  

2018 ◽  
Vol 12 (2) ◽  
pp. 135-145 ◽  
Author(s):  
Ik-Whan Kwon ◽  
Sung-Ho Kim

Purpose This paper aims to explore avenue where suppliers and manufacturers are aligned with health-care providers to improve supply chain visibility. Supply chain finance is explored to link suppliers/manufacturers with health-care providers. Design/methodology/approach Existing literature on supply chain visibility in health care forms a basis to achieve the study purpose. Alignment calls also for financial health where supply chain partners’ working capital is readily available to execute joint supply chain plan. Findings There is a disjoint in supply chain alliance between suppliers/manufacturers and providers where providers are unable to trace the origin of supplies. Quality care suffers and cost of care rises as providers search for supplies on an emergency basis. This paper provides a framework where solution can be formulated. Research limitations/implications Suppliers/manufactures form a direct strategic alliance with providers where product visibility enables health-care providers with a better patient management with lower cost of supplies. Inventory management and logistics cost will be lowered as better planning/forecasting is in place. This paper does not call for testing any hypothesis. Perhaps, next move along this line will be to investigate financial health of supply chain partners based on supplier relationship management practices. Originality/value This paper proposes health-care supply chain as an alternative solution to achieve the following twin purposes: controlling the cost while improving quality of care through supply chain finance. As far as we know, this study is the first attempt to achieve the goals.


Author(s):  
Breanne Cameron ◽  
Fay Cobb Payton

Along the health care supply chain, cost and quality measures are vital in the decision-making process for treatment and care delivery. This study applies statistical significance to a hypothesis about cost effectiveness of patients’ total charges by health insurance providers for different heart conditions. A retrospective, observational analysis of data is collected from an urban hospital in the Southeastern United States. Using the Agency for Healthcare Research and Quality (AHRQ) database, diagnoses are selected for further analysis based on their prevalence in the general population. The numbers of procedures as well as the patient’s length of stay in the hospital are significantly higher among the Medicare population. However, results indicate that although Medicaid and Medicare have significantly higher ordinary average total charges than the private counterparts, the difference is negligible when comparing means adjusted to remove covariate influence. One implication is that if private insurers were to insure the same types of high risk patients as Medicare and Medicaid the average total charges of a visit would be comparable between providers. These results also suggest that to enhance cost saving measures in government funded insurance programs, the clinical pathways need to be adapted to reduce length of stay and number of procedures per visit.


Sign in / Sign up

Export Citation Format

Share Document